$INSM SEC Filings

Filed On	Filing
20 Oct 2026	Form 4: Hudson Paul, Director Received 6,139 shares as a grant or award
20 Oct 2026	Form 3: Hudson Paul, Director No securities owned
20 Oct 2026	Form 4: Koppikar Utpal, Director Received 6,139 shares as a grant or award
20 Oct 2026	Form 3: Koppikar Utpal, Director No securities owned
20 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure —Paul Hudson, Former CEO of Sanofi and Novartis Pharmaceuticals, and Utpal Koppikar, CFO of Verily Health and Veteran Biopharma Finance Leader, Join as New Independent Directors—
05 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure —Sara Bonstein Will Step Down as CFO on October 30 After Nearly Seven Years of Dedicated Leadership—
11 Sep 2026	Form 4: Brennan David R, Director Sold 25,000 shares ($3.1M)
10 Sep 2026	144
19 Aug 2026	Form 4: Sharoky Melvin Md, Director Sold 5,000 shares ($638K)
17 Aug 2026	144
14 Aug 2026	SCHEDULE 13G/A
12 Aug 2026	Form 4: Adsett Roger, Chief Operating Officer Received 239,850 shares by exercise or conversion ($4.91M) · Sold 239,850 shares ($32M)
10 Aug 2026	144
07 Aug 2026	Form 4: Flammer Martina M.d., Chief Medical Officer Received 27,173 shares by exercise or conversion ($576K) · Sold 27,173 shares ($3.49M)
06 Aug 2026	144
06 Aug 2026	SCHEDULE 13G/A
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition
24 Jul 2026	Form 4: Lewis William, Director Received 10,700 shares by exercise or conversion ($267K) · Sold 10,700 shares ($1.13M)
23 Jul 2026	144

Comments